73.56 F
New York
July 31, 2021

Alzheimer's

Biogen’s controversial Alzheimer’s drug generates $2 million in first few weeks after approval

CNBC
CNBC – For more and to sign up click here Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug.......

How an Unproven Alzheimer’s Drug Got Approved

New York Times
The idea of accelerated approval came up briefly toward the end, raised by Dr. Rick Pazdur, head of F.D.A.’s oncology center, who was not a council member. It was not discussed in detail, but after the meeting, given the council’s rejection of standard approval, accelerated approval appeared to be the......

Biogen Alzheimer’s drug hits roadblocks with some hospitals, insurers

Reuters
July 15 (Reuters) – Biogen Inc’s (BIIB.O) Alzheimer’s drug, the first new treatment for the memory-robbing disease in nearly 20 years, hit new barriers on Thursday with some large hospitals declining to use it and health insurers delaying a decision while awaiting coverage terms from Medicare. An influential panel of......

How your driving might reveal early signs of Alzheimer’s

BBC
https://www.bbc.co.uk/news/business-57670006 Specifically, those with preclinical Alzheimer’s tended to drive more slowly, make abrupt changes, travel less at night, and logged fewer miles overall, for example. They also visited a smaller variety of destinations when driving, sticking to slightly more confined routes. BBC – For more and to sign up click......

How everyone on Medicare could end up paying for the pricey new Alzheimer’s drug

CNN
USA TODAY – For more and to sign up click here All of Medicare’s roughly 60 million enrollees will likely see their premiums rise to cover the new medication, experts say — and the burden will also fall to federal and state governments and, therefore, to taxpayers. Here’s how it’s......

F.D.A. Requests Investigation of Its Own Alzheimer’s Drug Approval

New York Times
The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease that has spurred sharp criticism from lawmakers and the medical community. In a letter to the Department of Health and Human Services’ independent......

Biogen stock falls after FDA calls for federal investigation into Alzheimer’s drug approval

CNBC
CNBC – For more and to sign up click here A sign marks a Biogen facility, in Cambridge, Massachusetts, March 9, 2020. Brian Snyder | Reuters Biogen shares fell on Friday after the head of the Food and Drug Administration called for an investigation into the recent approval of the......

Alzheimer’s made him forget he was married. He proposed to his wife again.

CBS News
CBS News – For more and to sign up click here Alzheimer’s made him forget he was married. He proposed to his wife again. – CBS News Watch CBSN Live Peter Marshall forgot his wife after he was diagnosed with early onset Alzheimer’s. Then he began courting her. Steve Hartman......

Patient receives first infusion of Biogen’s controversial Alzheimer’s drug

CNBC
CNBC – For more and to sign up click here The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images A 70-year-old man from Rhode Island on Wednesday was the first to receive an......

Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

CNBC
CNBC – For more and to sign up click here A sign for the Food and Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Sarah Silbiger | Getty Images A third member of a key Food and Drug Administration advisory panel has......

Biogen’s Alzheimer’s drug could cost Medicare billions of dollars a year, report finds

CNBC
CNBC – For more and to sign up click here A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen‘s pricy new Alzheimer’s drug, Aduhelm, could cost Medicare billions of dollars a year, according to an analysis......

New Insurrection Report, Ransom Recovery, Controversial Alzheimer’s Drug : Up First

NPR
NPR Two Senate committees released new findings related to the January 6th Capitol attack. The FBI recovered millions of the ransom Colonial Pipeline paid to suspected Russian hackers. The FDA has approved a pricey and controversial Alzheimer’s drug. NPR – Click for more...

FDA approves controversial Alzheimer’s drug

CBS News
CBS News – For more and to sign up click here FDA approves controversial Alzheimer’s drug – CBS News Watch CBSN Live The FDA approved the first Alzheimer’s drug in nearly 20 years. The agency’s decision drew controversy following warnings from independent advisers on the treatment known as Aduhelm. Dr.......

Dementia expert says evidence behind Biogen Alzheimer’s drug ‘wasn’t sufficient’ for FDA approval

CNBC
CNBC – For more and to sign up click here Dementia expert Dr. Jason Karlawish told CNBC he’s skeptical of the Food and Drug Administration’s approval of Biogen‘s Alzheimer’s disease drug, Aduhelm, saying “the evidence to approve the drug wasn’t sufficient.” “Another study is needed to establish whether this drug,......

Biogen shares surge 60% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

CNBC
CNBC – For more and to sign up click here The Food and Drug Administration on Monday approved Biogen‘s Alzheimer’s disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer’s and the first new medicine for the disease in......

U.S. FDA approves Biogen Alzheimer’s drug

Reuters
U.S. regulators on Monday approved Biogen Inc’s (BIIB.O) aducanumab as the first treatment to address an underlying cause of Alzheimer’s disease despite controversy over mixed clinical trial results for the drug. Aducanumab aims to remove sticky deposits of a protein called amyloid beta from the brains of patients in earlier......

Nearly all Alzheimer’s drugs fail, researchers say; Walking may help Parkinson’s

CBS News
CBS News – For more and to sign up click here Nearly all Alzheimer’s drugs fail, researchers say; Walking may help Parkinson’s – CBS News Watch CBSN Live The Cleveland Clinic released a study which found that 99 percent of all Alzheimer’s drugs developed in the past decade have failed.......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More